Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense is seeking information on commercial off-the-shelf solutions for a Biological Containment Isolation System (BCIS) to manage patients infected with high-consequence infectious diseases. Responses are due by October 10, 2025, and should detail system specifications, capabilities, and manufacturing information.
Note: This is a follow-on Request for Information (RFI) to two previous Sources Sought Announcements (links provided below) and is requesting more detailed information about readily available or commercial off the shelf (COTS) solutions for a system to support the Biocontainment, Isolation, and Quarantine (BIQ) Biological Containment Isolation System (BCIS) program.
Synopsis: The purpose of this RFI is to obtain detailed information to assist the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN Protection) in identifying readily available or COTS solutions for a transportable ground-based field deployable isolation area for personnel infected or suspected of infection with a High-Consequence Infectious Disease (HCID) that allows medical staff to monitor and/or treat patients while decreasing the risk of infecting other patients and staff.
The U.S. Government requests that responses be submitted via email ONLY to Brian Liska at brian.liska@usmc.mil no later than 10 OCT 2025 by 5:00 p.m. EST.
Background: To address the goals and objectives of the Chemical and Biological Defense Program (CBDP) Enhanced Biodefense and Pandemic Preparedness Narrative and the National Biodefense Strategy and Implementation Plan, JPM CBRN Protection is in need of a transportable ground-based field deployable BIQ capability for managing HCID infected patients during contingency operations, both CONUS and OCONUS. This RFI is issued to determine what solutions are available, and to obtain details about these systems to determine if they may be suitable for military use.
Description: The BCIS is a BIQ system that uses negative pressure with directional airflow and a filtration system to filter the exhaust air to contain airborne infectious particles within the area housing HCID-infected individuals. Other features such as, but not limited to, anterooms for doffing and donning personal protective equipment, interior lighting, heating and air conditioning, and windows are needed for medical staff to provide care to the patients. Additionally, the BCIS must be transportable via ground and air and setup in the field with minimal manpower and equipment. The BCIS will provide the government a ground-based field deployable isolation area for personnel infected or suspected of infection with an HCID and allow medical staff to monitor and/or treat patients while decreasing the risk of infecting other patients and staff.
Programs: This RFI is in support of the BCIS program, which is one of the three BIQ programs managed by JPM CBRN Protection. Requirements for BCIS system are currently being developed with contracting actions beginning in Fiscal Year 2026.
Government Furnished Property: None
Responses: Interested parties are invited to submit a response to this RFI.
This RFI is issued solely for information and planning purposes and to identify potential readily available or COTS solutions. THIS IS NOT A SOLICITATION. No contract will be awarded from this RFI. This RFI does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. It is subject to change and is not binding on the U.S. Government. Further, unsolicited proposals will not be accepted. Funding is not available at this time. The U.S. Government has not made a commitment to procure any of the items/services discussed, and release of this RFI should not be construed as such a commitment or as authorization to incur cost for which reimbursement would be required or sought. Response to this RFI is voluntary and no reimbursement will be made for any costs associated with providing information in response to this and any follow-on information requests. All submissions become U.S. Government property and will not be returned.
Not responding to this RFI does not preclude participation in any future RFP(s) if any is(are) issued.
Interested parties may identify their interest by submitting a white paper regarding this RFI to JPM CBRN Protection via e-mail ONLY to Brian Liska at brian.liska@usmc.mil no later than 10 OCT 2025 by 5:00 p.m. EST. Please include the following information in the white paper:
NOTE: Specification sheets, FDA clearance, reports, and/or manuals (operator and/or maintenance) may be included with the white paper.
The U.S. Government will not pay for any information or administrative cost incurred in response to this RFI. All costs associated with responding to this RFI will be solely at the expense of the interested party.
Questions: Any questions for clarification may be emailed to Brian Liska at brian.liska@usmc.mil no later than five business days before 10 OCT 2025. Please allow three business days for a response. Verbal questions will NOT be accepted. Questions shall NOT contain proprietary or classified information. An unattributed list of questions and answers will be published at the same web location of this RFI.
RFI - BIOCONTAINMENT, ISOLATION, AND QUARANTINE (BIQ) BIOLOGICAL CONTAINMENT ISOLATION SYSTEM (BCIS) is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.